POS-527 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Atrasentan in Patients with IgA Nephropathy (The ALIGN Study)

Saved in:
Bibliographic Details
Published in:Kidney international reports 2022-02, Vol.7 (2), p.S229-S230
Main Authors: Lambers Heerspink, H., Jardine, M., Kohan, D., Lafayette, R., Levin, A., Liew, A., Zhang, H., Glicklich, A., Camargo, M., King, A., Barratt, J.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2468-0249
2468-0249
DOI:10.1016/j.ekir.2022.01.558